Cystatin A promotes the antitumor activity of T helper type 1 cells and dendritic cells in murine models of pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is a disease with poor prognosis due to diagnostic and therapeutic limitations. We previously identified cystatin A (CSTA) as a PDAC biomarker and have conducted the present study to investigate the antitumor effects of CSTA. PDAC murine models were establishe...
Saved in:
| Main Authors: | Alessandro Nasti, Shingo Inagaki, Tuyen Thuy Bich Ho, Akihiro Seki, Keiko Yoshida, Kosuke Satomura, Yoshio Sakai, Shuichi Kaneko, Taro Yamashita |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | Molecular Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/1878-0261.13796 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overview of dendritic cells subsets and their involvement in immune-related pathological disease
by: Mohsen Abbaszadeh, et al.
Published: (2025-01-01) -
The thymic microenvironment gradually modulates the phenotype of thymus‐homing peripheral conventional dendritic cells
by: Susanne Herppich, et al.
Published: (2022-02-01) -
Red blood cell count and cystatin C as the specific biomarkers for diabetic retinopathy from diabetes mellitus: a case–control study
by: Zheng Li, et al.
Published: (2024-11-01) -
Serum cystatin C as a potential biomarker for generalized acetylcholine receptor antibody-positive myasthenia gravis
by: Dingxian He, et al.
Published: (2025-05-01) -
Prognostic value of serum cystatin C in patients with sepsis
by: Chunfang Hu, et al.
Published: (2023-07-01)